Berenberg Bank Downgrades Alliance Pharma (LON:APH) to Hold

Alliance Pharma (LON:APH) was downgraded by stock analysts at Berenberg Bank to a “hold” rating in a research note issued on Wednesday,Digital Look reports. They presently have a GBX 6,250 ($77.81) price target on the stock, down from their prior price target of GBX 7,000 ($87.15).

Alliance Pharma Stock Up 0.2 %

LON APH traded up GBX 0.10 ($0.00) during mid-day trading on Wednesday, hitting GBX 61.20 ($0.76). The company’s stock had a trading volume of 4,345,835 shares, compared to its average volume of 8,341,226. The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 47.46. The company’s 50 day simple moving average is GBX 50.26 and its 200 day simple moving average is GBX 44.25. The firm has a market capitalization of £330.83 million, a price-to-earnings ratio of -1,020.00, a PEG ratio of 1.04 and a beta of 0.67. Alliance Pharma has a twelve month low of GBX 24.55 ($0.31) and a twelve month high of GBX 61.60 ($0.77).

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.